{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihqjs64gbpov2ncchwjet26h4u73p5mz4yflc423gf5btcabcjgbe",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3miflg6pwlke2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreickru6yoldbl6smz4ey36al4ynw7x5t4rd56ifbrxw4cqrvolqveu"
    },
    "mimeType": "image/jpeg",
    "size": 92049
  },
  "path": "/2026/03/31/biogen-acquisition-apellis-immunology/?utm_campaign=rss",
  "publishedAt": "2026-03-31T11:47:11.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "biotechnology",
    "drug development",
    "Pharmaceuticals",
    "STAT+"
  ],
  "textContent": "Biogen is buying Apellis Pharmaceuticals for $5.6 billion upfront as it looks to expand its immunology business.",
  "title": "STAT+: Biogen to acquire immunology biotech Apellis for $5.6 billion",
  "updatedAt": "2026-03-31T11:54:57.000Z"
}